Evidence map›Paper›PMID 31178921›Full record

ArticleBioPsychoSocial medicine2019

Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.

Hitomi Kawanishi, Atsushi Sekiguchi, Misako Funaba, Yasushi Fujii, Kazuhiro Yoshiuchi, Hiroe Kikuchi, Keisuke Kawai, Kazushi Maruo, Norio Sugawara, Kenji Hatano and 9 more

Open access · goldAbstract read
In one paragraph

Article in BioPsychoSocial medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Hitomi Kawanishi1Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry (NCNP), Kodaira, 187-8553 Japan.
Atsushi Sekiguchi1Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry (NCNP), Kodaira, 187-8553 Japan.
Misako Funaba1Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry (NCNP), Kodaira, 187-8553 Japan.
Yasushi Fujii2Department of Psychology, Meisei University, Hino, Japan.
Kazuhiro Yoshiuchi3Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroe Kikuchi4Department of Psychosomatic Medicine, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
Keisuke Kawai5Department of Psychosomatic Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
Kazushi Maruo6Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan.
Norio Sugawara6Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan.
Kenji Hatano6Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan.
Tomotaka Shoji9Department of Psychosomatic Medicine, Tohoku University Hospital, Sendai, Japan.
Tadahiro Yamazaki3Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kenta Toda5Department of Psychosomatic Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
Masafumi Murakami5Department of Psychosomatic Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
Masayasu Shoji5Department of Psychosomatic Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
Chisato Ohara1Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry (NCNP), Kodaira, 187-8553 Japan.
Yoshitoshi TomitaDepartment of Psychosomatic Medicine, National Center Hospital of Neurology and Psychiatry, Kodaira, Japan.
Shin Fukudo8Department of Behavioral Medicine, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tetsuya Ando1Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry (NCNP), Kodaira, 187-8553 Japan.ORCID 0000-0003-2643-6067
National Center of Neurology and Psychiatry · JPNational Center for Global Health and Medicine · JPThe University of Tokyo · JPMeisei University · JPTohoku University · JPTohoku University Hospital · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is growing evidence of the treatment efficacy of cognitive behavioral therapy (CBT) for irritable bowel syndrome (IBS). CBT is recommended by several practice guidelines for patients with IBS if lifestyle advice or pharmacotherapy has been ineffective. Manual-based CBT using interoceptive exposure (IE), which focuses on the anxiety response to abdominal symptoms, has been reported to be more effective than other types of CBT. One flaw of CBT use in general practice is that it is time and effort consuming for therapists. Therefore, we developed a set of complementary video materials that include psycho-education and homework instructions for CBT patients, reducing time spent in face-to-face sessions while maintaining treatment effects. The purpose of this study is to examine the effects of CBT-IE with complementary video materials (CBT-IE-w/vid) in a multicenter randomized controlled trial (RCT).

methodsThis study will be a multicenter, parallel-design RCT. Participants diagnosed with IBS according to the Rome IV diagnostic criteria will be randomized to either the treatment as usual (TAU) group or the CBT-IE-w/vid + TAU group. CBT-IE-w/vid consists of 10 sessions (approximately 30 min face-to-face therapy + viewing a video prior to each session). Patients in the CBT-IE-w/vid group will be instructed to pre- view 3- to 13-min videos at home prior to each face-to-face therapy visit at a hospital. The primary outcome is the severity of IBS symptoms. All participants will be assessed at baseline, mid-treatment, post-treatment, and follow-up (3 months after post assessment). The sample will include 60 participants in each group. DISCUSSION: To our knowledge, this study will be the first RCT of manual-based CBT for IBS in Japan. By using psycho-educational video materials, the time and cost of therapy will be reduced. Manual based CBTs for IBS have not been widely adopted in Japan to date. If our CBT-IE-w/vid program is confirmed to be more effective than TAU, it will facilitate dissemination of cost-effective manual-based CBT in clinical settings.

trial registrationThe trial was registered to the University Hospital Medical Information Network Clinical Trial Registry: UMIN, No. UMIN000030620 (Date of registration: December 28, 2017).

Indexed as

Cognitive behavioral therapyHome-based self-managementInteroceptive exposureIrritable bowel syndromeMulticenterRandomized controlled trialRefractory IBSVideo materials

Identifiers

PMID31178921
PMCPMC6551860
OpenAlexW2948480363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.